Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Promising results in AcouSort’s latest feasibility study with Instrumentation Laboratory

AcouSort has finalized the recent feasibility project with Instrumentation Laboratory (IL) concerning generation of blood plasma aiming to expand the use of AcouSort’s technology in additional IL product lines. The project results have been very promising, lining up for additional feasibility studies addressing blood-plasma separation together with IL.– We are very pleased by the successful execution of the latest project together with IL and by the results generated within the project showing significant potential. We have over the last years managed to further strengthen our close

Valmet to supply technology for Spinnova-Suzano joint venture textile fibre factory in Finland

Valmet Oyj’s press release on May 17, 2021 at 11:00 a.m. EETValmet will supply drying technology to Spinnova-Suzano joint venture textile fibre factory in Jyväskylä, Finland. The facility, producing SPINNOVA® fibre, is the first step towards scaling production volumes to one million tonnes annually within ten years. Spinnova’s annual capacity could be 50,000 tonnes of textile fibre by 2024. The order is included in Valmet's orders received of the second quarter 2021. The value of the order will not be disclosed. Spinnova and Suzano recently announced 

Falkor joins Liquid Wind to develop eMethanol facilities in France

The French low-carbon investment firm, Falkor, joins Liquid Wind as a minority equity investor and co-development partner. Falkor will leverage Liquid Wind’s expertise to efficiently replicate eMethanol facilities in France and Southern Europe.Liquid Wind is a power-to-fuel development company, which develops commercial-scale facilities for the production of carbon neutral fuel, eMethanol. Together with their consortium partners, Alfa Laval, Carbon Clean, Haldor Topsoe and Siemens Energy, Liquid Wind is developing a standardised and modular facility model. They will use the latest

Clean Energy for All Sites in Western Europe

Mannheim (Germany), May 17, 2021 – The RKW Group is continuously expanding its commitment to climate protection and sustainability. After converting its German sites to green electricity last year, the company will also be using clean energy from renewable sources such as wind, solar and hydroelectric power in France and Belgium from June 2021. The bottom line is an estimated annual saving of probably 100,000 tonnes of CO\2\ – in relation to the electricity consumption of the 18 plants worldwide, this corresponds to a reduction of more than 60 percent."As the RKW Group, we are committed to

NCC divests Road Services Denmark to Mutares

NCC divests Road Services Denmark to the German based holding company Mutares (Frankfurt Stock Exchange: MUX). The transaction is expected to have a marginal positive effect on NCC earnings and cash flow in connection with closing, expected in the second quarter. NCC took the decision to divest the Road Services division since it has few synergies with other parts of the business and has been loss-making, but it is a business that can develop well in another context. In July 2020, the Swedish and Finnish part of Road Services were divested to Mutares, who now acquires also the

Scandinavian ChemoTech has passed the final revision of IQwave and increases its chances of CE marking before the deadline

ChemoTech can now sum up great progress after completing the three-day long and intensive revision of the Company's quality system and review of its critical processes required for CE marking of medical devices in the EU.After a comprehensive revision (on-site - via video) of the Company's quality system and all processes prior to the CE marking, which was carried out last week, only a final review of a few documents submitted on 12 May now remains. “Even though we have not secured our CE marking yet, we are proud to have passed the physical revision, which is the most critical part of

Outcome in issue of warrants

Örnsköldsvik, Sweden. The Board of Directors of Clavister Holding AB resolved, with the support of an issue authorization from the Annual General Meeting 2020, to issue no more than 1.605.331 warrants, without consideration, to the European Investment Bank (“EIB”), in accordance with an agreement entered into with EIB in December 2017. EIB has subscribed for all 1.605.331 warrants. The Board of Directors has resolved to allot all subscribed warrants to EIB. For more information regarding this press release, please contact:John Vestberg, President and CEO, +46 (0)660-29 92 00 or ir@

Invitation to Fractal Gaming Groups Interim Report for the first quarter of 2021

Fractal Gaming Group AB will publish its interim report for the period of January-March 2021, Friday, May 21, 2021 at 08.00 (CET). In conjunction to this, a telephone and web conference will be held for investors, analysts and media on the same day at 09.00 (CET). CEO, Hannes Wallin and CFO, Karin Ingemarsson will present and comment on the report and will be followed by a question and answer session.To attend the telephone or web conference:SE: +46850558368UK: +443333009266US: +18446251570 Link to web conference: https://tv.streamfabriken.com/fractal-gaming-group-q1-2021For

Risk Intelligence A/S secures a major contract with high profile London based Law Firm

Risk Intelligence A/S (“Risk Intelligence” or "the Company") announces today that the Company has secured a significant contract for its Advisory Services business area with a major London based law firm.The Company’s security specialists will be providing expert witness and background analysis to assist the law firm whilst it represents a sovereign government. The contract will in addition to other already delivered and confirmed bespoke projects more than triple revenue within Advisory Services during first half of 2021 compared to 2020. The contract does not change the Company’s

AFRY acquires Pinja Industry Oy in Finland - experts in engineering and automation solutions

With the acquisition, AFRY will strengthen the digital and automation offer in the industry sector.AFRY has signed an agreement to acquire Pinja Industry Oy, a company focusing on engineering, automation and machine vision as well as testing and quality assurance services for the industry sector. The acquired business is specialized in providing engineering services and digital solutions for demanding industrial and production environments, for the full lifecycle of the clients’ business. Their services range from consulting to engineering, and implementation to maintenance and optimization.

Prostatype Genomics publishes Annual Report for 2019/20

Prostatype Genomics AB today publishes the Annual Report for the extended financial year of July 2019 to December 2020. The Annual Report is attached as a PDF and is available on the company's webpage: www.prostatypegenomics.comAbout Prostatype Genomics   Prostatype Genomics AB manufactures, markets and sells the prognostic gene testProstatype®. By giving a assessment of the aggressiveness of the prostate cancer,Prostatype® helps clinicians and patients to make correct treatment decisions.Over and under treatment of prostate cancer can be minimized, the quality of life forthe

Brighter Makes Progress with the User Experience Test of the Diabetes Management Solution Actiste

Brighter AB [publ], today announced the User Experience collaboration with two Swedish health centers, one in Halland and the other in Västra Götaland, is making progress. Brighter´s senior diabetes nurse Lisa Malm shares her observations from onboarded patients. “Feedback has been very positive from patients regarding the functions of the Actiste service, especially for the Brighter app that aims for patients to get a clear overview of treatment data to better manage their diabetes,” says Lisa Malm. All treatment data logged on the Actiste device is automatically synced with the

BioStock: BiBBInstruments remains optimistic despite temporary pause in studies

BiBBInstruments recently published the report for the first quarter of 2021, in which the main event was the start of the pilot study with the biopsy instrument EndoDrill Model X in bladder cancer. However, production problems at a supplier have led to a temporary pause in patient recruitment, but the company remains optimistic as they expect the studies to resume in the second quarter. In addition, the company sees the long-term potential and benefits of the electric endoscopic biopsy instrument.Read the full article at biostock.se: https://www.biostock.se/en/bibbinstruments-remains-

Iconovo extends agreement with Amneal for generic Symbicort to cover key markets U.S. and China, as well as Nordic sales rights

Iconovo AB (publ), which develops complete inhalation products for a global market, today announced that its collaboration with the U.S. pharmaceutical company Amneal is expanding to include additional territories that lead to the announced potential for future annual royalty income more than doubling to USD 13.2 – 26.4 million. Iconovo has also acquired the license to sell Amneal's generic versions of Symbicort® in the Nordic region with the potential to generate revenues between USD 9.5 – 11.9 million.Iconovo and Amneal develop a generic Symbicort in the inhaler ICOres®. The project is

Growing Number of Bio-engineering Companies Purchase HoloMonitor

In the course of regular business, the regenerative medicine company Pandorum Technology  recently purchased a complete HoloMonitor system. The cell analysis system from PHI was evaluated and com­mis­sioned at Pandorum’s R&D lab in Charleston at the Medical University of South Carolina. Regenerative medicine and cell-based therapies promise to cure common but severe diseases such as diabetes, Parkinson’s, and several cancer forms. HoloMonitor has the ability to analyze individual cells without reagents or other harmful effects in a controlled cell culture

European LED iBond patents now also set to include data communication features

LED iBond International’s (LED iBond) European patent process for patent family 4A is moving forward. The company has recently received confirmation that the European Patent Organisation, EPO has issued a “positive office action” for the patent, which includes the idea of using the sandwiched aluminium layers of Tracy® and other LED iBond products for data exchange with LEDs and third-party devices simultaneously with providing power for these components. With this confirmation from EPO, LED iBond has now decided to take the next steps to follow up on this opportunity to secure

Froosh bottles get a limited-edition summer outfit

Froosh is launching four new limited-edition designs in May where the fruit icons from the bottles are re-designed to summer emojis.Froosh is known for giving tribute to fruit in its smoothies with the tagline "it's just fruit". For the summer, four of the flavours change to summer clothes in a limited edition. The bestsellers Mango & Orange and Blueberry & Raspberry together with flavours Peach & Passion and Pineapple, Banana & Coconut now have a new summer design.– Just in time for summer some of Froosh most beloved flavours are flirting with all the wonderful moments of coming summer

Technical trading halt in Frill's share during Monday, May 17, 2021

STOCKHOLM, May 17, 2021 08:30 CET An administrative error when changing and registering a new ISIN code for Frill's share has resulted in a technical stop for trading in Frill's share on Monday. Trading in Frill's share is expected to resume on Tuesday, May 18, 2021 with a new ISIN code and a new short name.During Frill's Extraordinary General Meeting on December 15, 2020, it was decided to adopt new Articles of Association, whereby Frill's various classes of shares were taken away. When registering this change, the human factor resulted in a mistake and the correct information about the

Episealer®: Presentation from ESSKA 2021 available online

Episurf Medical (Nasdaq: EPIS B) today announces that the presentation "Episealer mini metal implant in the Knee and Ankle” by Associate Professor Tim Spalding from University Hospitals Coventry and Warwickshire NHS Trust, UK, and Professor Niek van Dijk from the FIFA Medical Center of Excellence, Madrid, Spain, which was presented at the 19[th] ESSKA congress during the previous week, will be made available today, Monday May 17[th], on Episurf Medical’s website (www.episurf.com/healthcare-professionals/scientific-presentations). The presentation covers Episurf Medical’s technology for both

Interim Financial Report – first three months of 2021 (Q1 2021)

SGL TransGroup International A/S (SGL Group) has today published its Interim Financial Report for the first three months of 2021 (Q1 2021). SGL Group (SGL TransGroup International A/S) · For SGL Group, the Q1 2021 revenue was DKK 1,653.8m versus DKK 1,101.9m in Q1 2020; an increase of 50% driven by an overall increase of activities for Air and Ocean activities in Nordics and Asia Pacific and an increase in freight rates globally. · The total Gross Profit was DKK 239.3m; equivalent to a Gross Margin of 14.5% · The Q1 2021 EBITDA before special items and excluding IFRS 16 was

The exercise period for exercising the warrants of series TO4 begins today, Monday May 17, 2021

Today, Monday may 17, 2021, begins the exercise period for the exercising of the warrants of series TO4, that were issued in conjunction with Cyxone AB (publ)’s (”Cyxone” or ”the Company”) directed issue of units during the fourth quarter of 2020. In conjunction with the exercise periods beginning, Cyxone also publishes a letter to the warrant holders, including words from the CEO and instructions for how to exercise the warrants. The exercise price has been set to SEK 3.24 per new share and if all warrants are exercised, the Company will receive approximately SEK 19.5 million before issuing

Relais Group Plc is investigating the possibility of transferring its shares to Nasdaq Helsinki Main Market

Relais Group Plc, Company release 17.5.2021 at 9.25 EET Relais Group Plc is investigating the possibility of transferring its shares to Nasdaq Helsinki Main Market The Board of Directors of Relais Group Plc (“Company”, “Relais”), a leading consolidator in the Nordic vehicle aftermarket, has decided to investigate the possibility of transferring the Company’s shares to Nasdaq Helsinki Main Market during 2022 at the earliest. Relais Group Plc’s shares have been listed on the Nasdaq First North Growth Market Finland since October 2019. In the Company’s view, transferring the shares to

EQT Public Value enters irrevocable undertaking to accept Palace Bidco’s Tender Offer for Adapteo at a 53 percent bid premium

EQT is today announcing that the EQT Public Value Fund (“EQT Public Value”) has signed an irrevocable undertaking to accept the Tender Offer made today through Palace Bidco Oy by West Street Global Infrastructure Partners IV, L.P., an infrastructure fund managed by Goldman Sachs Asset Management for the shares in Adapteo Plc (“Adapteo”). The price amounts to SEK 165.0 per Adapteo share, representing a 53 percent bid premium compared to the closing price per 14 May 2021, the last day of trading prior to the Tender Offer announcement, and a 66 percent premium to the volume-weighted average

Relais Group Plc sets a new long-term net sales target. The aim is to reach net sales of 500 MEUR by the end of 2026.

Relais Group Plc, Company Release 17.5.2021 at 9.20 EET Relais Group Plc sets a new long-term net sales target. The aim is to reach net sales of 500 MEUR by the end of 2026. Relais Group Plc (“Company”, “Relais”), a leading consolidator in the Nordic vehicle aftermarket, recalibrates its strategy and sets a new long-term net sales target. Relais has uncompromisingly executed its strategy published during its First North listing in 2019 with the cornerstones of active and targeted acquisitions, organic growth above average market level, and creating added value for the customers

There are no items matching the current filter
There are no more items matching the current filter
Back to top